Breastlink Medical Group

Breastlink

About Breastlink

Comprehensive breast centers to help women with breast cancer treatment, prevention, screening and diagnosis.

Review of the 2013 SABCS

Bevacizumab | 2013 SABCS | BreastlinkThe San Antonio Breast Cancer Symposium (SABCS) is an annual international conference directed towards academicians, private physicians and researchers with more than 7,000 in attendance from 90 countries. The purpose of the symposium is to relay breaking news, trial updates, advances in biology and practice-changing guidelines in breast cancer care and management.

Breastlink sends a team of physicians and researchers to SABCS every year to gather critical updates and research advances. We then disseminate the results to patients, referring physicians and the Breastlink medical team. Last year, for example, the results of the ATLAS trial delivered at the 2012 […]

By | February 3, 2014|Categories: Cancer News, Cancer Research|Tags: , |0 Comments

Nipple-Sparing Mastectomy (Areola-Sparing Mastectomy)

A woman born today in the United States has a one in eight chance of developing breast cancer. For women diagnosed with breast cancer, the two main treatment options are:

  • Lumpectomy with radiation (removal of the cancer with a small amount of breast tissue) or
  • Mastectomy (removal of all breast tissue).

Mastectomy surgery has improved significantly in the last two decades. Once considered a disfiguring procedure, current techniques for mastectomy and reconstruction can give women results that allow them to feel whole.

Nipple Sparing Mastectomy (Areola-Sparing Mastectomy)

Nipple-sparing mastectomy (also referred to as areola-sparing mastectomy) has been a significant advancement for women requiring mastectomy for breast cancer treatment. This procedure is also an […]

By | January 28, 2014|Categories: Breast Surgery|Tags: |0 Comments

SABCS 2013 – Anastrozole

The 2013 San Antonio Breast Cancer Symposium was an engaging and invigorating event – I look forward to sharing what I have learned with colleagues and patients. If you have any specific questions you would like me to address about this year’s Symposium please feel free to leave a comment to this blog post or contact my office.

Dr. Nimmi Kapoor and I will also be sharing our observations from this year’s San Antonio Breast Cancer Symposium in a series of community lectures in January. We will share details when they are confirmed.

Here are a few observations from the plenary sessions I attended on Thursday and Friday.

Anastrozole May Provide New Option […]

By | December 17, 2013|Categories: Cancer Research, Oncology|Tags: , |0 Comments

2013 SABCS Wednesday Oncology Observations

The inaugural day of the 2013 San Antonio Breast Cancer Symposium introduced new insights with treatment implications. I believe patients diagnosed with HER2-positive breast cancer(s) will find of two studies of particular interest:

NeoALTTO Trial (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimization). This is an ongoing phase III clinical trial that is evaluating if a combination of trastuzumab and lapatinib (two HER2-targeted therapy agents) is better than only one of the HER2-targeted therapies. The published findings showed a moderate benefit to adding lapitinib (tykerb) to trastuzumab (herceptin) prior to surgery while significantly increasing side effects.

The same research team will present the results of the ALTTO trial (Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization) at the […]

By | December 12, 2013|Categories: Cancer Research, Oncology|Tags: |0 Comments

2013 SABCS Preview

A guest blog post from Breastlink Research Development Manager Barbara Stankova.

This is an exciting time in breast cancer research and treatment. We are nearing an era where we can help patients with personalized therapies that specifically target the genetic profile of a patient’s breast cancer tumor(s). The ability to only target cancerous tumors will lead to treatment options that are far more effective – and successful – than traditional breast cancer treatment options.

One of the most motivating annual events for breast cancer advocates and researchers is the San Antonio Breast Cancer Symposium (SABCS). Not only are some of the most significant research findings announced during the five day event, it […]

By | December 10, 2013|Categories: Cancer Research|Tags: |0 Comments

Breastlink to Offer C-View 3D Breast Imaging Technology

First center in Orange County to provide benefits of 3D breast imaging without increased radiation or additional compression time compared to standard 3D mammography.

3d breast imaging Orange County BreastlinkLAGUNA HILLS Calif., December 9, 2013 – Breastlink, a network of comprehensive breast health centers, and West Coast Breast Centers, both operated by wholly-owned subsidiaries of RadNet, Inc., which manages a network of outpatient imaging and cancer treatment centers, announced West Coast Breast Center at Breastlink of Laguna Hills will be the first medical center in Orange County to offer women 3D mammography with Hologic C-View imaging software.

Breast tomosynthesis (3D breast imaging) is an imaging technique […]

By | December 9, 2013|Categories: Breast Cancer Screening, Press Releases|Tags: |0 Comments

Breastlink Laguna Hills Now Open

Breastlink Laguna Hills is the First Comprehensive, Multi-Disciplinary Outpatient Breast Center in South Orange County

Practice combines the experience of Breastlink, Advanced Breast Care Specialists of Orange County and West Coast Breast Centers.

Breastlink Laguna Hills | Advanced Breast Care SpecialistsLAGUNA HILLS, Calif., November 26, 2013 – Breastlink, a network of comprehensive breast health centers operated by a wholly-owned subsidiary of RadNet, Inc., which manages a network of outpatient imaging and cancer treatment centers, announced West Coast Breast Center at Breastlink Laguna Hills, a comprehensive, multi disciplinary breast care center, is now open to help South Orange County women achieve optimal breast health outcomes. […]

By | November 26, 2013|Categories: Press Releases|Tags: |0 Comments

QOPI Certification & Quality Oncology Care

At Breastlink we have always sought to respond to patient needs in a comprehensive way. I believe this requires responding to the patient as a whole person – not to a diagnosis.

I also believe we are charged with a broader imperative – to constantly review what we do. To help ensure we provide optimal breast cancer treatment it is essential for us to be informed by clinical experience and to understand the latest developments in breast cancer research.

As a practice, it means that we choose to be accountable not only, most importantly, to our patients, but to be scrutinized by an organization that sets the standards of oncology excellence across […]

By | November 21, 2013|Categories: Oncology|Tags: |0 Comments

Adding Perjeta to the Treatment of HER2-Positive Tumors Prior to Surgery

perjetaPertuzumab (Perjeta) became the first drug to ever be approved by the FDA for use prior to surgery for non-metastatic breast cancer on September 30, 2013. This development further signals a paradigm shift away from chemotherapy and towards targeted therapy – specifically in the now increasingly target-rich environment of HER2-positive breast cancer.

What is Perjeta?

Pertuzumab is a monoclonal antibody, which works by preventing a molecular interaction between the HER2 receptor and other related receptors on the breast cancer cell’s surface. We’ve known about the effectiveness of pertuzumab based on a prior trial with over 800 patients (CLEOPATRA).

What is HER2 positive <a href=[…]

By | November 13, 2013|Categories: Oncology|Tags: |0 Comments

Breast Reconstruction and Cosmetic Surgery

A New Study on Breast Cancer Patients Pursuing Cosmetic Surgery after Breast Reconstruction

Breast reconstruction is an important part of breast cancer treatment with the purpose of restoring a woman’s form and self-esteem. A new study presented at the annual meeting for the American Society of Plastic Surgeons (ASPS) in San Diego found that many women who have had breast reconstruction go on to have other cosmetic surgical procedures such as body contouring or facial rejuvenation to further improve their self-image.

In this study, out of University of Pennsylvania and MD Anderson Cancer Center in Houston, researchers looked at 1,214 women who had breast reconstruction between 2005 and 2012. Of these […]

By | October 31, 2013|Categories: Breast Surgery|Tags: , |0 Comments
Load More Posts